Stock listing
Kelyniam Global, Inc.
Selected listing: KLYG · OTC · USD · US
Kelyniam Global, Inc. (OTC:KLYG), Health Technology. Latest release Aug 11, 2026: Kelyniam Global Announces Q2 2026 Financial Results.
- Ticker
- OTC:KLYG
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Kelyniam Global, Inc.
The company operates in the technology sector, focusing on innovative solutions and products. Kelyniam aims to enhance its market presence and deliver value to its stakeholders.
Latest news from Kelyniam Global, Inc.
Kelyniam Global Announces Q2 2026 Financial Results
August 11, 2026
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
June 1, 2026
Kelyniam Global Announces Strong Q1 2026 Financial Results
May 11, 2026
Kelyniam Global Reports 2025 Financial Results
March 16, 2026
Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 13, 2025
Research Kelyniam Global, Inc.
Kelyniam Global, Inc. company profile
View the public company page for Kelyniam Global, Inc. on 6ix.
Kelyniam Global, Inc. news
Read company news and market updates connected to Kelyniam Global, Inc..
Kelyniam Global, Inc. investor events
Find investor webinars, events, and replay context for Kelyniam Global, Inc..